Bio-Rad Laboratories Class B
BIO.B
7 hedge funds and large institutions have $3.79M invested in Bio-Rad Laboratories Class B in 2014 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
5% more capital invested
Capital invested by funds: $3.6M → $3.79M (+$191K)
0.01% more ownership
Funds ownership: 0.58% → 0.58% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
U
UBS
Zurich,
Switzerland
|
+$19.9K |
| 2 |
Citigroup
New York
|
+$11K |
| 3 |
Invesco
Atlanta,
Georgia
|
+$5.52K |
| 4 |
Barclays
London,
United Kingdom
|
+$770 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $2.86M | – | – | – |
|
2
Dimensional Fund Advisors
Austin,
Texas
| $823K | – | – | – |
|
|
U
3
UBS
Zurich,
Switzerland
| $88K | +$19.9K | +155 | +29% |
|
|
4
Invesco
Atlanta,
Georgia
| $13K | +$5.52K | +43 | +81% |
|
|
5
Citigroup
New York
| $11K | +$11K | +86 | New |
|
|
6
Barclays
London,
United Kingdom
| $3K | +$770 | +6 | +35% |
|
BIO.B Hedge Fund Activity: Q1 2014 in Review
7 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q1 2014, worth a combined $3.79M — up 5.3% from $3.6M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIO.B positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.
The largest buyer was UBS, adding an estimated $19.9K.
- 7 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q1 2014, up from 6 in Q4 2013.
- Funds reported $3.79M of Bio-Rad Laboratories Class B stock for Q1 2014, up 5.3% quarter-over-quarter.
- 1 fund opened new Bio-Rad Laboratories Class B positions in Q1 2014 and 0 closed out, a net change of +1 holder.
- The largest Bio-Rad Laboratories Class B buyer in Q1 2014 was UBS, an estimated $19.9K added.
Based on aggregated 13F filings for Q1 2014.